Nautilus Biotechnology, Inc.·4

Mar 1, 5:17 PM ET

Weld Gwen E 4

4 · Nautilus Biotechnology, Inc. · Filed Mar 1, 2023

Insider Transaction Report

Form 4
Period: 2023-02-27
Weld Gwen E
Chief People Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-27+160,000160,000 total
    Exercise: $2.00Exp: 2033-02-27Common Stock (160,000 underlying)
Footnotes (1)
  • [F1]Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is January 1, 2023.

Documents

1 file
  • 4
    wf-form4_167770904055529.xmlPrimary

    FORM 4